Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
Published November 29, 2017 · Recall initiated: September 28, 2017
Summary
FDA records drug Class II recall D-0085-2018, published November 29, 2017 and initiated September 28, 2017. Recalling firm: Leading Pharma, LLC; Status: Terminated; Reported quantity: 2952 500-count bottles; Lot: Lot #E00717. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
What to do
Voluntary: Firm initiated · Letter
Get an email if LORAZEPAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LORAZEPAM
- Manufacturer
- Leading Pharma, LLC
- Distributor
- Nationwide in the USA
- UPC
- 0369315905104
- Lot
- Lot #E00717
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJAugust 6, 2025
- FDALorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDALorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDALorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDANo. 1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by Shata TradersNovember 29, 2017
- FDAExtra Strength Naturally HL Bed Sore Relief Cream with Added Lidocaine, (lidocaine HCL 4%), 1/2 oz Balm(NDCNovember 29, 2017
Questions about this recall
Was Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05 recalled?
Yes. FDA published recall D-0085-2018 on November 29, 2017. Reported hazard: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LORAZEPAM. UPC: 0369315905104.